Efficacy of cocktail phage therapy in treating Vibrio cholerae infection in rabbit model

Microbes and Infection

Volumn 15, Issue 2, 2013, Pages 152-156

  Jaiswal, Abhishek ^a   Koley, Hemanta ^a   Ghosh, Amit ^a   Palit, Anup ^a   Sarkar, Banwarilal ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Lytic; Oral administration; Phage cocktail; Vibrio cholerae; Vibriophage

Indexed keywords

MAK 757; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; CHOLERA; CONTROLLED STUDY; DIARRHEA; FECES ANALYSIS; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SURVIVAL; VIBRIO CHOLERAE; VIBRIOPHAGE;

ADMINISTRATION, ORAL; ANIMALS; BACTERIOPHAGES; CHOLERA; COLONY COUNT, MICROBIAL; FECES; FEMALE; MALE; MODELS, ANIMAL; RABBITS; TIME FACTORS; VIBRIO CHOLERAE; VIRAL PLAQUE ASSAY;

BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; VIBRIO CHOLERAE;

EID: 84872859301     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.11.002     Document Type: Article

References (22)

1. WHO Cholera: global surveillance summary 2008. Wkly. Epidemiol. Rec. 2009, 84:309-324.
2. Cash R.A., Music S.I., Libonati J.P., Snyder M.J., Wenzel R.P., Hornick R.B. Response of man to infection with Vibrio Cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J. Infect. Dis. 1974, 129:45-52.
3. Sack D.A., Sack R.B., Nair G.B., Siddique A.K. Cholera. Lancet 2004, 363:223-233.
4. Garg P., Sinha S., Chakraborty R., Bhattacharya S.K., Nair G.B., Ramamurthy T., Takeda Y. Emergence of fluoroquinolone resistant strains of Vibrio Cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India. Antimicrobial Agents Chemother. 2001, 45:1605-1606.
5. Jain M., Kumar P., Goel A.K., Kamboj D.V., Singh L. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India. Int. J. Antimicrob. Agents Chemother. 2008, 32:459-460.
6. Sulaxvelidze A., Alavidze Z., Morris J.G. Bacteriophage therapy. Antimicrobial Agents Chemother. 2001, 45:649-659.
7. Mcvay C.S., Velasquez M., Fralick J.A. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrobial Agents Chemother. 2007, 51:1934-1938.
8. Biswas B., Adhya S., Washart P., Paul B., Trostel A.N., Powell B., Carlton R., Merril C.R. Phage therapy rescues mice bacteraemia from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 2002, 70:204-210.
9. Cray W.C., Tokunaga E., Pierce N.F. Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. Infect. Immun. 1983, 41:735-741.
10. Koley H., Ghosh A.N., Paul M., Ghosh A.R., Ganguly P.K., Nair G.B. Colonization ability & intestinal pathology of rabbits orally fed with Vibrio cholerae O139 Bengal. Indian J. Med. Res. 1995, 101:57-61.
11. Bhowmick T.S., Koley H., Das M., Saha D.R., Sarkar B.L. Pathogenic potential of vibriophages against an experimental infection with Vibrio cholerae O1 in the RITARD model. Int. J. Antimicrob. Agents 2009, 33:569-573.
12. Chattopadhyay D.J., Sarkar B.L., Ansari M.Q., Chakrabarti B.K., Roy M.K., Ghosh A.N., Pal S.C. New phage typing scheme for Vibrio cholerae O1 biotype El Tor strains. J. Clin. Microbiol. 1993, 31:1579-1585.
13. Russell R.G., Tall B.D., Morris J.G. Non-O1 Vibrio cholerae intestinal pathology and invasion in the removable intestinal tie adult rabbit diarrhea model. Infect. Immun. 1992, 60:435-442.
14. Wills Q.F., Kerrigan C., Soothill J.S. Experimental phage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrobial Agents Chemother. 2005, 49:1220-1221.
15. Zahid M.S., Udden S.M., Faruque A.S., Calderwood S.B., Mekalanos J.J., Faruque S.M. Effect of phage on the infectivity of Vibrio cholerae and emergence of genetic variants. Infect. Immun. 2008, 76:5266-5273.
16. Ling Y.L., Meng A.H., Zhao X.Y., Shan B.E., Zhang J.L., Zhang X.P. Effect of cholecystokinin on cytokines during endotoxic shock in rats. World J. Gastroenterol. 2001, 7:667-671.
17. Soothill J.S. Treatment of experimental infections of mice with bacteriophages. J. Med. Microbiol. 1992, 37:258-261.
18. Hanlon G.W. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents 2007, 30:118-128.
19. Cislo M., Dabrowski M., Weber-Dabrowska B., Woyton A. Bacteriophage treatment of suppurative skin infections. Arch. Immunol. Ther. Exp. 1987, 35:175-183.
20. Monsur K.A., Rahman M.A., Huq F., Islam M.N., Northrup R.S., Hirschhorn N. Effect of massive doses of bacteriophage on excretion of vibrios, duration of diarrhoea and output of stools in acute cases of cholera. Bull. World Health Organ. 1970, 42:723-732.
21. Marcuk L.M., Nikiforov V.N., Scerbak J.F., Levitov T.A., Kotljarova R.I., Naumsina M.S., Davydov S.U., Monsur K.A., Rahman M.A., Latif M.A., Northrup R.S., Cash R.A., Hug I., Dey C.R., Phillips R.A. Clinical studies of the use of bacteriophage in the treatment of cholera. Bull. World Health Organ. 1971, 45:77-83.
22. Sarkar B.L., De S.P., Saha M.R., Niyogi S.K., Roy M.K. Validity of new phage typing scheme against Vibrio cholerae 01 biotype El Tor strains. Indian J. Med. Res. 1994, 99:159-161.